Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta‐analysis

Published:2022-10-22 Issue: Volume: Page:
ISSN:1354-523X
Container-title:Oral Diseases
language:en
Short-container-title:Oral Diseases

Author:

Monteiro Luis¹²^ORCID,Mariano Lorena C.²^ORCID,Warnakulasuriya Saman³^ORCID

Affiliation:

1. Medicine and Oral Surgery Department University Institute of Health Sciences (IUCS), CESPU Gandra Portugal

2. UNIPRO, Oral Pathology and Rehabilitation Research Unit University Institute of Health Sciences (IUCS), CESPU Gandra Portugal

3. Faculty of Dentistry, Oral & Craniofacial Sciences King's College London, and the WHO Collaborating Centre for Oral Cancer London UK

Publisher

Wiley

Subject

General Dentistry,Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.14378

Reference39 articles.

1. Malignant transformation of oral leukoplakia: Systematic review and meta‐analysis of the last 5 years

2. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation

3. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia

4. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia—A systematic review of retrospective studies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of podoplanin inhibitors in controlling oral cancer progression;Archives of Oral Biology;2024-01